| Scott R Mcafee, MD | |
|
23320 Highway 99, Edmonds, WA 98026-8744 | |
| (425) 640-5500 | |
| (425) 582-5580 |
| Full Name | Scott R Mcafee |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 35 Years |
| Location | 23320 Highway 99, Edmonds, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255484630 | NPI | - | NPPES |
| 8135667 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD00029041 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Community Health Center Of Snohomish County | 0446152003 | 62 |
News Archive
Merck, known as MSD outside the United States and Canada, and Idenix Pharmaceuticals, Inc., today announced that the companies have entered into a definitive agreement under which Merck will acquire Idenix for $24.50 per share in cash.
Ludwig Cancer Research announced today that it is opening a new Branch in Lausanne, Switzerland. The Branch will be focused primarily on applied cancer immunology and the design of novel molecular and cell-based immunotherapies. It will also develop technologies enabling the efficient, safe application of those therapies to as many patients as possible.
Providing forearm support is an effective way to prevent musculoskeletal disorders of the upper body and helps reduce upper body pain associated with computer work, according to a study reported in the April 18 issue of the British Journal of Occupational and Environmental Medicine.
GenMark Diagnostics, Inc., a provider of automated, multiplex molecular diagnostic testing systems, announced today that its initial public offering of 4,600,000 shares of its common stock has been priced at $6.00 per share. The shares are expected to begin trading today on the NASDAQ Global Market under the ticker symbol "GNMK." In addition, GenMark has granted the underwriters a 30-day option to purchase up to an additional 690,000 shares to cover over-allotments, if any.
High blood pressure is a well-known risk factor for heart disease. Researchers at the Sahlgrenska Academy at the University of Gothenburg, Sweden, have participated in an international study of 200,000 Europeans which has identified 16 new genetic variations that affect blood pressure. The discovery, presented in Nature, is an important step towards better diagnostics and treatment.
› Verified 2 days ago
| Entity Name | Community Health Center Of Snohomish County |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730136367 PECOS PAC ID: 0446152003 Enrollment ID: O20040123000395 |
News Archive
Merck, known as MSD outside the United States and Canada, and Idenix Pharmaceuticals, Inc., today announced that the companies have entered into a definitive agreement under which Merck will acquire Idenix for $24.50 per share in cash.
Ludwig Cancer Research announced today that it is opening a new Branch in Lausanne, Switzerland. The Branch will be focused primarily on applied cancer immunology and the design of novel molecular and cell-based immunotherapies. It will also develop technologies enabling the efficient, safe application of those therapies to as many patients as possible.
Providing forearm support is an effective way to prevent musculoskeletal disorders of the upper body and helps reduce upper body pain associated with computer work, according to a study reported in the April 18 issue of the British Journal of Occupational and Environmental Medicine.
GenMark Diagnostics, Inc., a provider of automated, multiplex molecular diagnostic testing systems, announced today that its initial public offering of 4,600,000 shares of its common stock has been priced at $6.00 per share. The shares are expected to begin trading today on the NASDAQ Global Market under the ticker symbol "GNMK." In addition, GenMark has granted the underwriters a 30-day option to purchase up to an additional 690,000 shares to cover over-allotments, if any.
High blood pressure is a well-known risk factor for heart disease. Researchers at the Sahlgrenska Academy at the University of Gothenburg, Sweden, have participated in an international study of 200,000 Europeans which has identified 16 new genetic variations that affect blood pressure. The discovery, presented in Nature, is an important step towards better diagnostics and treatment.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Scott R Mcafee, MD 23320 Highway 99, Edmonds, WA 98026-8744 Ph: (425) 640-5500 | Scott R Mcafee, MD 23320 Highway 99, Edmonds, WA 98026-8744 Ph: (425) 640-5500 |
News Archive
Merck, known as MSD outside the United States and Canada, and Idenix Pharmaceuticals, Inc., today announced that the companies have entered into a definitive agreement under which Merck will acquire Idenix for $24.50 per share in cash.
Ludwig Cancer Research announced today that it is opening a new Branch in Lausanne, Switzerland. The Branch will be focused primarily on applied cancer immunology and the design of novel molecular and cell-based immunotherapies. It will also develop technologies enabling the efficient, safe application of those therapies to as many patients as possible.
Providing forearm support is an effective way to prevent musculoskeletal disorders of the upper body and helps reduce upper body pain associated with computer work, according to a study reported in the April 18 issue of the British Journal of Occupational and Environmental Medicine.
GenMark Diagnostics, Inc., a provider of automated, multiplex molecular diagnostic testing systems, announced today that its initial public offering of 4,600,000 shares of its common stock has been priced at $6.00 per share. The shares are expected to begin trading today on the NASDAQ Global Market under the ticker symbol "GNMK." In addition, GenMark has granted the underwriters a 30-day option to purchase up to an additional 690,000 shares to cover over-allotments, if any.
High blood pressure is a well-known risk factor for heart disease. Researchers at the Sahlgrenska Academy at the University of Gothenburg, Sweden, have participated in an international study of 200,000 Europeans which has identified 16 new genetic variations that affect blood pressure. The discovery, presented in Nature, is an important step towards better diagnostics and treatment.
› Verified 2 days ago
Clifford John Johnson, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7320 179th St Sw, Edmonds, WA 98026 Phone: 425-743-5160 Fax: 425-743-5160 | |
Joe M Skariah, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 21911 76th Ave W, #110, Edmonds, WA 98026 Phone: 425-640-4950 Fax: 425-640-4958 | |
Louis P. Gianutsos, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7315 212th St Sw Ste 101, Edmonds, WA 98026 Phone: 425-775-9474 Fax: 425-670-3554 | |
Steven Koh, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 21600 Highway 99 Ste 280, Edmonds, WA 98026 Phone: 360-901-6355 | |
Michelle R Richards, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 23320 Highway 99, Edmonds, WA 98026 Phone: 425-640-5500 | |
Dr. Emmy Nakasu Davison, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 21911 76th Ave W, Suite 110, Edmonds, WA 98026 Phone: 425-640-4950 Fax: 425-640-4958 | |
Monica Kimberly Park, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 7315 212th St Sw Ste 101, Edmonds, WA 98026 Phone: 425-775-9474 Fax: 425-670-3554 |